Table: begin end state 1 31 cytoplasmic 32 53 transmembrane 54 63 non-cytoplasmic 64 87 transmembrane 88 98 cytoplasmic 99 118 transmembrane 119 122 non-cytoplasmic 123 147 transmembrane 148 166 cytoplasmic 167 191 transmembrane 192 200 non-cytoplasmic 201 219 transmembrane 220 260 cytoplasmic 261 279 transmembrane 280 298 non-cytoplasmic 299 319 transmembrane 320 327 cytoplasmic 328 347 transmembrane 348 352 non-cytoplasmic 353 377 transmembrane 378 388 cytoplasmic 389 412 transmembrane 413 417 non-cytoplasmic 418 439 transmembrane 440 500 cytoplasmic
Input: >GFF2891 FitnessBrowser__WCS417:GFF2891 MKLRKKSVKPIGLKDITIVDDTKVRKAITAAALGNAMEWFDFGVYGFVAYVLGKVFFPDA SPSVQMIAALGTFSVPFLIRPLGGLFFGALGDKYGRQKVLAATIVIMSLSTFAIGLIPSY ASIGIWAPILLLLCKMAQGFSVGGEYTGASIFVAEYAPDRKRGFLGSWLDFGSIAGFVLG AGVVVLISSILGEADFESWGWRLPFFLALPLGIIGLYLRHALEETPAFQQHMDKMEQGDR EGLTHGPKVSFKEVATKHWRSLLTCIGIVAATNVTYYMLLTYMPSYLSHNLHYKENSGVL IIIAIMVGMLFVQPFIGFISDKIGRKPFIIAGSIGLLFLSIPAFMLITSGKIGLIFAGLL ILAVILNFFIGVMASTLPAMFPTHLRYSALASAFNVSVLIAGLTPTAVAWLVESTNDLYM PAYYLMVFAVVGLITGLTMKETANKPLRGAAPAASDMEEAKELLQEHHDNIEQKIEDIDA EIAELEAKRKNLVEQHPRIN
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server